Publications

A comparison of cluster and systematic sampling methods for measuring crude mortality.

Abstract

OBJECTIVE: To compare the results of two different survey sampling techniques (cluster and systematic) used to measure retrospective mortality on the same population at about the same time.

Rose AM Grais RF Coulombier D Ritter H
Bulletin of the World Health Organization 2006 Apr ; 84(4); 290-6. doi: /S0042-96862006000400013. Epub 2006 04 13

Geographical distribution of selected and putatively neutral SNPs in Southeast Asian malaria parasites.

Abstract

Loci targeted by directional selection are expected to show elevated geographical population structure relative to neutral loci, and a flurry of recent papers have used this rationale to search for genome regions involved in adaptation.

Anderson TJ Nair S Sudimack D Williams JT Mayxay M Newton PN Guthmann JP Smithuis FM Tran TH van den Broek IV White NJ Nosten F
Molecular biology and evolution 2005 Dec ; 22(12); 2362-74. doi: 10.1093/molbev/msi235. Epub 2005 08 10

Diagnostic accuracy of two rK39 antigen-based dipsticks and the formol gel test for rapid diagnosis of visceral leishmaniasis in northeastern Uganda.

Abstract

The development of an accurate, practical, and affordable diagnostic test is essential to improve the management of visceral leishmaniasis (VL) in remote health centers.

Chappuis F Mueller Y Nguimfack A Rwakimari JB Couffignal S Boelaert M Cavailler P Loutan L Piola P
Journal of clinical microbiology 2005 Dec ; 43(12); 5973-7. doi: 10.1128/JCM.43.12.5973-5977.2005. Epub 2006 01 19

Genetic heterogeneity of hepatitis E virus in Darfur, Sudan, and neighboring Chad.

Abstract

The within-outbreak diversity of hepatitis E virus (HEV) was studied during the outbreak of hepatitis E that occurred in Sudan in 2004.

Nicand E Armstrong GL Enouf V Guthmann JP Guerin JP Caron M Nizou JY Andraghetti R
Journal of medical virology 2005 Dec ; 77(4); 519-21. doi: 10.1002/jmv.20487. Epub 2006 01 17

Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004.

Abstract

The state of Bihar in India carries the largest share of the world's burden of antimony-resistant visceral leishmaniasis. We analysed clinical studies done in Bihar with different treatments between 1980 and 2004.

Olliaro PL Guerin PJ Gerstl S Haaskjold AA Rottingen JA Sundar S
The Lancet. Infectious diseases 2005 Dec ; 5(12); 763-74. doi: 10.1016/S1473-3099(05)70296-6. Epub 2005 12 29

Does one size fit all? Drug resistance and standard treatments: results of six tuberculosis programmes in former Soviet countries.

Abstract

SETTING: After the collapse of the Soviet Union, countries in the region faced a dramatic increase in tuberculosis cases and the emergence of drug resistance.

Bonnet M Sizaire V Kebede Y Janin A Doshetov D Mirzoian B Arzumanian A Muminov T Iona E Rigouts L Rüsch-Gerdes S Varaine F
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2005 Oct ; 9(10); 1147-54. doi: . Epub 2006 01 03

Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh.

Abstract

Bangladesh faces growing levels of Plasmodium falciparum resistance to chloroquine (CQ) and sulfadoxine-pyrimethamine (SP). Alternative antimalarial therapies, particularly combination regimens, need to be considered.

van den Broek IV Maung UA Peters A Liem L Kamal M Rahman M Rahman MR Bangali AM Das S Barends M Faiz AM
Transactions of the Royal Society of Tropical Medicine and Hygiene 2005 Oct ; 99(10); 727-35. doi: 10.1016/j.trstmh.2005.02.007. Epub 2006 01 17

Control of mucocutaneous leishmaniasis, a neglected disease: results of a control programme in Satipo Province, Peru.

Abstract

Mucocutaneous leishmaniasis (MCL) is an important health problem in many rural areas of Latin America, but there are few data on the results of programmatic approaches to control the disease.

Guthmann JP Arlt D Garcia LM Rosales M de Jesus Sanchez J Alvarez E Lonlas S Conte M Bertoletti G Fournier C Huari R Torreele E Llanos-Cuentas A
Tropical medicine & international health : TM & IH 2005 Sep ; 10(9); 856-62. doi: 10.1111/j.1365-3156.2005.01460.x. Epub 2005 10 06

Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study.

Abstract

BACKGROUND: In sub-Saharan Africa in the 1990s, more than 600,000 people had epidemic meningococcal meningitis, of whom 10% died. The current recommended treatment by WHO is short-course long-acting oily chloramphenicol.

Nathan N Borel T Djibo A Evans D Djibo S Corty JF Guillerm M Alberti KP Pinoges L Guerin PJ Legros D
Lancet (London, England) ; 366(9482); 308-13. doi: 10.1016/S0140-6736(05)66792-X. Epub 2005 10 04